Senescent Epithelial Cell Targeting and Microbiota Therapy for IBD
SUMMARY Improved inflammatory bowel disease (IBD) management by identifying and therapeutically targeting senescent colonic epithelial cells, thereby reducing mucosal inflammation through depletion of these pro-inflammatory cells The Unmet Need: Insufficient therapeutic targeting of epithelial components in inflammatory bowel disease Inflammatory bowel disease, including ulcerative colitis and Crohn’s disease, is a chronic… Read More